Min Zhou, MD, Ph.D

Affiliations: 
Neuroscience Ohio State University, Columbus, Columbus, OH 
Area:
Glial cells
Website:
http://biomed.osu.edu/neuroscience/19647.cfm
Google:
"Min Zhou"
Mean distance: 30533.1
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yang L, Zhang H, Zhou M, et al. (2020) High-Stable X-ray Imaging from All-Inorganic Perovskite Nanocrystals under a High Dose Radiation. The Journal of Physical Chemistry Letters. 9203-9209
Wang W, Kiyoshi CM, Du Y, et al. (2019) TREK-1 Null Impairs Neuronal Excitability, Synaptic Plasticity, and Cognitive Function. Molecular Neurobiology
Li Y, Qi Y, Zhang H, et al. (2019) Gram-scale synthesis of highly biocompatible and intravenous injectable hafnium oxide nanocrystal with enhanced radiotherapy efficacy for cancer theranostic. Biomaterials. 226: 119538
You HM, Zhao JW, Jing YX, et al. (2019) Bioactive glycosides from Salacia cochinchinensis. Carbohydrate Research. 484: 107777
Chen B, Zhou M, Zhang H, et al. (2019) TREM1/Dap12-based CAR-T cells show potent antitumor activity. Immunotherapy
Zhang L, Wang MJ, Wang W, et al. (2019) Identification of driver genes and somatic mutations in cell-free DNA of patients with pulmonary lymphangioleiomyomatosis. International Journal of Cancer
Zhou M, Liu M, Wang J, et al. (2019) Polydiaminoanthraquinones with tunable redox properties as high performance organic cathodes for K-ion batteries. Chemical Communications (Cambridge, England)
Zhang H, Huang H, Zhang Y, et al. (2018) Comparison of Chimney Technique and Single-Branched Stent Graft for Treating Patients with Type B Aortic Dissections that Involved the Left Subclavian Artery. Cardiovascular and Interventional Radiology
Chen H, He R, Shi X, et al. (2018) Meta-analysis on resected pancreatic cancer: a comparison between adjuvant treatments and gemcitabine alone. Bmc Cancer. 18: 1034
Guo X, Jiang H, Shi B, et al. (2018) Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma. Frontiers in Pharmacology. 9: 1118
See more...